Dolby Laboratories, Inc. (DLB) Major Shareholder Dagmar Dolby Sells 100,000 Shares

Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of the stock in a transaction that occurred on Friday, May 18th. The stock was sold at an average price of $62.49, for a total value of $6,249,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Wednesday, May 16th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.82, for a total value of $6,282,000.00.
  • On Monday, May 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.65, for a total value of $6,265,000.00.
  • On Thursday, May 10th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.23, for a total value of $6,223,000.00.
  • On Tuesday, May 8th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.78, for a total value of $6,178,000.00.
  • On Friday, May 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.03, for a total value of $6,103,000.00.
  • On Wednesday, May 2nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $60.81, for a total value of $6,081,000.00.
  • On Friday, April 27th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $60.39, for a total value of $3,019,500.00.
  • On Monday, April 30th, Dagmar Dolby sold 88,538 shares of Dolby Laboratories stock. The shares were sold at an average price of $60.28, for a total value of $5,337,070.64.

Dolby Laboratories opened at $62.43 on Tuesday, MarketBeat Ratings reports. The firm has a market capitalization of $6.50 billion, a price-to-earnings ratio of 28.38, a price-to-earnings-growth ratio of 2.25 and a beta of 0.76. Dolby Laboratories, Inc. has a 12 month low of $48.00 and a 12 month high of $74.29.

Dolby Laboratories (NYSE:DLB) last posted its earnings results on Tuesday, April 24th. The electronics maker reported $0.78 EPS for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.14. The business had revenue of $301.36 million during the quarter, compared to analyst estimates of $300.37 million. Dolby Laboratories had a return on equity of 12.73% and a net margin of 7.64%. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.63 EPS. sell-side analysts expect that Dolby Laboratories, Inc. will post 2.31 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 16th. Investors of record on Monday, May 7th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend was Friday, May 4th. Dolby Laboratories’s payout ratio is currently 29.09%.

Several institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. grew its holdings in shares of Dolby Laboratories by 0.8% in the fourth quarter. BlackRock Inc. now owns 3,092,122 shares of the electronics maker’s stock worth $191,712,000 after acquiring an additional 25,262 shares during the period. Timucuan Asset Management Inc. FL grew its holdings in shares of Dolby Laboratories by 0.7% in the fourth quarter. Timucuan Asset Management Inc. FL now owns 1,221,424 shares of the electronics maker’s stock worth $75,728,000 after acquiring an additional 8,110 shares during the period. Allianz Asset Management GmbH grew its holdings in shares of Dolby Laboratories by 107.3% in the first quarter. Allianz Asset Management GmbH now owns 1,167,119 shares of the electronics maker’s stock worth $74,182,000 after acquiring an additional 604,109 shares during the period. Thrivent Financial for Lutherans grew its holdings in shares of Dolby Laboratories by 0.5% in the first quarter. Thrivent Financial for Lutherans now owns 952,117 shares of the electronics maker’s stock worth $60,517,000 after acquiring an additional 4,967 shares during the period. Finally, Thrivent Financial For Lutherans grew its holdings in shares of Dolby Laboratories by 2.2% in the fourth quarter. Thrivent Financial For Lutherans now owns 947,150 shares of the electronics maker’s stock worth $58,723,000 after acquiring an additional 20,610 shares during the period. 53.73% of the stock is owned by institutional investors.

A number of research analysts have issued reports on the company. Barrington Research reiterated a “buy” rating and set a $78.00 price objective on shares of Dolby Laboratories in a research note on Tuesday, May 1st. Zacks Investment Research lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Friday, April 27th. ValuEngine raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. B. Riley lowered Dolby Laboratories to a “hold” rating and set a $63.00 target price for the company. in a report on Thursday, January 25th. Finally, JPMorgan Chase lifted their target price on Dolby Laboratories from $63.00 to $70.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $66.50.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply